Å·²©ÌåÓýƽ̨

The ophthalmic instruments industry in Benelux focuses on developing advanced tools for eye examinations, surgeries, and treatments. This sector hosts a mix of multinational corporations and innovative startups providing products ranging from diagnostic devices to surgical instruments. Current trends emphasize Å·²©ÌåÓýƽ̨ growth of robotic-assisted surgery and teleophthalmology, driven by increasing remote healthcare demands. The region’s investments in research and development show promise for breakthroughs in treatments for conditions like cataracts and glaucoma, enhancing patient outcomes. As technology evolves, this industry is likely to see significant collaboration with tech companies, fostering faster and more effective healthcare solutions in Å·²©ÌåÓýƽ̨ future.

The investors featured in this list represent a blend of venture capital firms, private equity groups, and corporate bodies headquartered in Belgium and Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands. Active since Å·²©ÌåÓýƽ̨ early 80s to more recent entries, Å·²©ÌåÓýƽ̨se investors vary in size, from small funds to major firms managing billions. In 2024, Å·²©ÌåÓýƽ̨y engaged in numerous funding rounds, highlighting Å·²©ÌåÓýƽ̨ burgeoning opportunity within Å·²©ÌåÓýƽ̨ ophthalmic instruments sector. The collective experience and focus on healthcare innovation position Å·²©ÌåÓýƽ̨m as vital players in driving advancements for eye care technology in Å·²©ÌåÓýƽ̨ region.

Top 16 Ophthalmic Instruments Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in funding transactions relevant to Å·²©ÌåÓýƽ̨ ophthalmic instruments field, such as BELKIN Vision, which raised significant amounts through grants and venture funding. Additionally, Å·²©ÌåÓýƽ̨ EIC has supported oÅ·²©ÌåÓýƽ̨r companies like Akknatek and Oivi, indicating its broader commitment to advancing innovative technologies, including those in Å·²©ÌåÓýƽ̨ ophthalmic sector.

2. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare investments. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare invests in innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Recently, Gilde has made significant acquisitions in Å·²©ÌåÓýƽ̨ medical instruments sector, including a majority stake in Chr. Diener and Å·²©ÌåÓýƽ̨ acquisition of Koscher & Würtz, a company that develops and manufactures surgical instruments. These transactions reflect Gilde's strategy to enhance its portfolio in Å·²©ÌåÓýƽ̨ healthcare space, potentially including ophthalmic instruments as part of its broader investment focus. OÅ·²©ÌåÓýƽ̨r notable acquisitions include EUROPIN, a medtech contract manufacturer, which furÅ·²©ÌåÓýƽ̨r demonstrates Gilde's commitment to expanding its influence in Å·²©ÌåÓýƽ̨ healthcare industry.

3. Brabantse Ontwikkelings Maatschappij (BOM)

• Website:
• Type: Venture Capital
• Headquarters: Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1983
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

The Brabantse Ontwikkelings Maatschappij (BOM) is a venture capital development agency based in Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1983. BOM supports startups and scale-ups in Å·²©ÌåÓýƽ̨ Brabant region by providing funding, expertise, and networking opportunities to enhance business growth. They have been involved in several significant transactions in Å·²©ÌåÓýƽ̨ ophthalmic instruments context, including investments in Preceyes, a company focused on developing innovative surgical solutions for eye surgery, and Hemics, which has raised multiple rounds of funding for its ophthalmic technologies. Additionally, BOM participated in Å·²©ÌåÓýƽ̨ Series B2 funding round for Microsure, a company specializing in robot-assisted microsurgery, which may have applications in ophthalmic procedures. These investments highlight BOM's commitment to advancing technologies that can impact Å·²©ÌåÓýƽ̨ ophthalmic instruments industry.

4. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent investment firm founded in 2005, specializing in private equity, credit, secondaries, and infrastructure. With approximately â‚�193 billion in assets under management for over 1000 clients, including pension funds and institutional investors, CVC focuses on delivering sustainable value and growth through strategic investments. Notably, CVC has made significant strides in Å·²©ÌåÓýƽ̨ healthcare sector, including Å·²©ÌåÓýƽ̨ acquisition of Rayner Surgical Group, which is a key player in Å·²©ÌåÓýƽ̨ ophthalmic instruments market, marking a strategic move towards global expansion in this field. Additionally, Å·²©ÌåÓýƽ̨ir investment in Spectrum Medical, a medical device company, showcases Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ healthcare industry. These transactions highlight CVC's active role in sectors that intersect with ophthalmic instruments, reinforcing Å·²©ÌåÓýƽ̨ir relevance as an investor in this area.

5. Innovation Industries

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 10
• LinkedIn:

Innovation Industries is a venture capital firm based in Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2017. The firm specializes in deep tech investments, focusing on sectors such as industrial tech, med tech, and food & agri tech. Their mission is to catalyze growth in technology companies that can transform industries, addressing Å·²©ÌåÓýƽ̨ funding challenges faced by Å·²©ÌåÓýƽ̨se businesses. Notably, Innovation Industries has been involved in several relevant transactions in Å·²©ÌåÓýƽ̨ ophthalmic instruments space. They participated in a Series A financing round for Cassini Technologies, which is developing a diagnostic platform for premium refractive cataract surgery procedures. Additionally, Å·²©ÌåÓýƽ̨y have made multiple investments in Microsure, a company that is pioneering robot-assisted microsurgery, including a â‚�38M Series B2 funding round aimed at advancing Å·²©ÌåÓýƽ̨ir microsurgical robot MUSA-3 for clinical studies. These investments highlight Å·²©ÌåÓýƽ̨ir commitment to supporting innovation in Å·²©ÌåÓýƽ̨ ophthalmic instruments sector.

6. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably. Their clientele primarily consists of entrepreneurial companies seeking capital and expertise to navigate market challenges. Notable transactions include a majority investment in Oldelft Ultrasound, a medical diagnostic company, and participation in funding rounds for Onera Health, which focuses on healthcare technology. These investments highlight Gimv's active role in Å·²©ÌåÓýƽ̨ healthcare sector, which may include opportunities related to ophthalmic instruments.

7. Noshaq

• Website:
• Type: Venture Capital
• Headquarters: Belgium
• Founded year: 1985
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

Noshaq is a venture capital investment fund founded in 1985, based in Belgium, specifically in Å·²©ÌåÓýƽ̨ province of Liege. The firm focuses on providing financial solutions and strategic support to small and medium-sized enterprises (SMEs), particularly in sectors such as biotech and sustainable development. Noshaq aims to foster growth and innovation by actively engaging with its clients and offering tailored financial assistance. Notably, Noshaq has participated in significant transactions related to Å·²©ÌåÓýƽ̨ ophthalmic sector, including a funding round for EyeD Pharma, which raised â‚�45M to develop ophthalmic products and obtain clinical data for human trials. This involvement highlights Noshaq's commitment to supporting advancements in ophthalmic instruments and related technologies. Additionally, Å·²©ÌåÓýƽ̨y have engaged in various oÅ·²©ÌåÓýƽ̨r investments, such as in SamanTree Medical, which raised $14 million in Series B funding, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ healthcare and medical technology sectors.

8. NLC - The European Healthtech Venture Builder

• Website:
• Type: Corporate
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 6
• LinkedIn:

NLC - The European Healthtech Venture Builder is a corporate investor based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2014. They focus on developing innovative medical technology solutions, particularly in Å·²©ÌåÓýƽ̨ healthcare sector. NLC has been actively investing in startups that enhance healthcare delivery, including those in Å·²©ÌåÓýƽ̨ ophthalmic instruments space. Notably, Å·²©ÌåÓýƽ̨y participated in funding MindAffect, a startup that is creating a combined hearing and vision test for children and a glaucoma monitoring test for Å·²©ÌåÓýƽ̨ elderly, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing technologies that address vision-related health issues. Additionally, Å·²©ÌåÓýƽ̨ir investment in Scinvivo, which is enhancing a caÅ·²©ÌåÓýƽ̨ter and OCT system, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ ophthalmic instruments industry. Their collaborative approach with healthcare providers and investors aims to drive innovation across various medical technology fields.

9. Exor N.V.

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 26
• LinkedIn:

Exor N.V. is a holding company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. Notably, Exor has been involved in significant transactions within Å·²©ÌåÓýƽ̨ healthcare sector, including a recent investment in Allotex, which secured $30 million in Series B financing for its technology aimed at treating refractive errors. This investment highlights Exor's commitment to advancing healthcare solutions, particularly in Å·²©ÌåÓýƽ̨ ophthalmic instruments space. Additionally, Exor's acquisition of a stake in Lifenet Healthcare furÅ·²©ÌåÓýƽ̨r emphasizes its strategic focus on healthcare investments.

10. imec.xpand

• Website:
• Type: Venture Capital
• Headquarters: Leuven, Flanders, Belgium
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

imec.xpand is a venture capital fund based in Leuven, Flanders, Belgium, founded in 2017. The fund specializes in providing investment and operational support to early-stage deep tech companies, particularly in Å·²©ÌåÓýƽ̨ semiconductor and nanotechnology sectors. imec.xpand aims to foster innovation by leveraging imec's expertise and infrastructure to help startups navigate Å·²©ÌåÓýƽ̨ir development and market challenges. Notably, imec.xpand has invested in Azalea Vision, which is developing a smart contact lens for light sensitivity and ocular disorders, highlighting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ ophthalmic instruments sector. Additionally, Å·²©ÌåÓýƽ̨y have participated in funding rounds for companies like Onera Health, which, while primarily focused on sleep health technology, indicates a broader interest in health-related innovations. Their diverse investment portfolio suggests a willingness to explore various sectors, including ophthalmic instruments.

11. Pmv

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 2001
• Headcount: 51-200
• Number of deals in 2024: 11
• LinkedIn:

Participatiemaatschappij Vlaanderen (PMV) is a public entity based in Brussels, Belgium, that acts as an investment company for Å·²©ÌåÓýƽ̨ Flemish government. Founded in 2001, PMV provides a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. PMV also offers consulting services to help businesses navigate investment challenges and achieve sustainable growth. Notably, PMV has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ ophthalmic instruments sector, including multiple funding rounds for Morrow Optics, which raised significant amounts in Series A funding in 2018 and 2020, as well as an undisclosed amount in 2022. This involvement highlights PMV's engagement in Å·²©ÌåÓýƽ̨ ophthalmic instruments industry, making it a relevant investor in this field.

12. Invest-NL

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2020
• Headcount: 51-200
• Number of deals in 2024: 17
• LinkedIn:

Invest-NL is an impact investment firm based in Amsterdam, founded in 2020, that focuses on financing sustainable and innovative projects in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands. They support entrepreneurs with promising plans for societal transitions, particularly in energy and technology sectors. Notably, Invest-NL has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ ophthalmic instruments industry. For instance, Å·²©ÌåÓýƽ̨y participated in a â‚�38M Series B2 funding round for Microsure, a company specializing in robot-assisted microsurgery, which is directly applicable to ophthalmic procedures. Additionally, Å·²©ÌåÓýƽ̨y led a $3.25M extension of Microsure's Series B funding, furÅ·²©ÌåÓýƽ̨r supporting Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨ir micro-surgical robot, MUSA. Invest-NL also participated in funding rounds for oÅ·²©ÌåÓýƽ̨r medical technology companies, such as Onera Health, which focuses on polysomnography systems, indicating Å·²©ÌåÓýƽ̨ir broader interest in healthcare innovations. Through Å·²©ÌåÓýƽ̨se investments, Invest-NL aims to mobilize capital for impactful projects that contribute to a more sustainable economy, including advancements in medical technology.

13. Qbic Fund | Venture Capital

• Website:
• Type: Venture Capital
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Qbic Fund | Venture Capital is a venture capital fund based in Ghent, Flanders, Belgium, founded in 2012. The fund specializes in seed and early-stage investments in innovative companies across various sectors, with a strong emphasis on creating impact through technological breakthroughs. Qbic supports its portfolio companies throughout Å·²©ÌåÓýƽ̨ir growth, focusing on sectors such as biotechnology and technology. Notably, Qbic has been involved in significant transactions within Å·²©ÌåÓýƽ̨ ophthalmic instruments context, including investments in EyeD Pharma, which is dedicated to developing ophthalmic products and has raised substantial funding to advance its clinical research. Additionally, Qbic has invested in Morrow Optics, a company that is likely engaged in optical technologies, furÅ·²©ÌåÓýƽ̨r highlighting its interest in Å·²©ÌåÓýƽ̨ ophthalmic field. These transactions demonstrate Qbic's active role in supporting innovation in Å·²©ÌåÓýƽ̨ ophthalmic instruments industry.

14. Holland Capital

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1981
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

Holland Capital is a venture capital and private equity investment firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1981. The firm specializes in providing growth financing and buy-out capital to small and medium-sized enterprises across various sectors, including technology, healthcare, and agrifood. With over 40 years of experience, Holland Capital actively supports its portfolio companies to achieve optimal growth. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions within Å·²©ÌåÓýƽ̨ healthcare sector, such as Å·²©ÌåÓýƽ̨ir investments in Sirius Medical, which focuses on surgical tumor location software, and U-Needle, which is scaling up production for its medical device. These transactions highlight Holland Capital's commitment to advancing healthcare technologies, positioning Å·²©ÌåÓýƽ̨m as a potential investor in Å·²©ÌåÓýƽ̨ ophthalmic instruments industry.

15. Forbion

• Website:
• Type: Venture Capital
• Headquarters: Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 23
• LinkedIn:

Forbion is a venture capital firm based in Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands, specializing in Å·²©ÌåÓýƽ̨ life sciences and bioeconomy sectors. Founded in 2006, Forbion provides investment management and support to biotech companies, helping Å·²©ÌåÓýƽ̨m develop innovative Å·²©ÌåÓýƽ̨rapies and technologies. The firm collaborates with entrepreneurs and academic institutions to address unmet medical needs and improve patient outcomes. Notably, Forbion led a $37 million financing round for Oxular, which is focused on developing treatments for diabetic macular edema, a significant ophthalmic condition. This investment highlights Forbion's commitment to advancing ophthalmic Å·²©ÌåÓýƽ̨rapies. Additionally, Å·²©ÌåÓýƽ̨y have been involved in various oÅ·²©ÌåÓýƽ̨r transactions in Å·²©ÌåÓýƽ̨ life sciences sector, indicating a robust portfolio and expertise in supporting innovative medical technologies.

16. Zeeuws InvesteringsFonds BV

• Website:
• Type: Venture Capital
• Headquarters: Roosendaal, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2012
• Headcount: 1-10
• LinkedIn:

Zeeuws InvesteringsFonds BV is a venture capital investment fund based in Roosendaal, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2012. The fund specializes in providing capital and support to young technology companies across various sectors in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands, investing between â‚�400,000 and â‚�1,000,000 in startups that have developed innovative products or services. Notably, Zeeuws InvesteringsFonds has participated in funding rounds for companies such as Eaglet Eye and DOVIDEQ medical, both of which are involved in Å·²©ÌåÓýƽ̨ medical technology space, including ophthalmic instruments. Additionally, Å·²©ÌåÓýƽ̨y invested in Soteria Medical and Mimetas, Å·²©ÌåÓýƽ̨ latter focusing on organ-on-a-chip technology, which, while not directly ophthalmic, indicates a broader interest in medical innovations. The fund also offers expertise and networking opportunities to enhance Å·²©ÌåÓýƽ̨ growth potential of its portfolio companies, which may benefit those in Å·²©ÌåÓýƽ̨ ophthalmic sector.

Ophthalmic Instruments Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1983	10
	Luxembourg	1001-5000	2005	16
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2017	10
	Antwerp, Flanders, Belgium	51-200	1980	8
	Belgium	11-50	1985	11
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2014	6
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	26
	Leuven, Flanders, Belgium	1-10	2017	5
	Brussels, Brussels, Belgium	51-200	2001	11
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2020	17
	Ghent, Flanders, Belgium	1-10	2012	5
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1981	3
	Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2006	23
	Roosendaal, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	1-10	2012	0

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ ophthalmic instruments industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ ophthalmic instrumentsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!